APA

Lelli G., Cataldo S., Carandina I., Urbini B., Bonetti F., Marzola M., Biasco G., Pantaleo M. A., Brandes A., Calandri C., Ravaioli E., Nanni O., Boni C., Banzi C., Negri F., Panetta A., DI Fabio F. & Turci D. (20080804). The role of cetuximab in pre-treated refractory patients with metastatic colorectal cancer: outcome study in clinical practice. : Journal of chemotherapy (Florence, Italy).

Chicago

Lelli G, Cataldo S, Carandina I, Urbini B, Bonetti F, Marzola M, Biasco G, Pantaleo M A, Brandes A, Calandri C, Ravaioli E, Nanni O, Boni C, Banzi C, Negri F, Panetta A, DI Fabio F and Turci D. 20080804. The role of cetuximab in pre-treated refractory patients with metastatic colorectal cancer: outcome study in clinical practice. : Journal of chemotherapy (Florence, Italy).

Harvard

Lelli G., Cataldo S., Carandina I., Urbini B., Bonetti F., Marzola M., Biasco G., Pantaleo M. A., Brandes A., Calandri C., Ravaioli E., Nanni O., Boni C., Banzi C., Negri F., Panetta A., DI Fabio F. and Turci D. (20080804). The role of cetuximab in pre-treated refractory patients with metastatic colorectal cancer: outcome study in clinical practice. : Journal of chemotherapy (Florence, Italy).

MLA

Lelli G, Cataldo S, Carandina I, Urbini B, Bonetti F, Marzola M, Biasco G, Pantaleo M A, Brandes A, Calandri C, Ravaioli E, Nanni O, Boni C, Banzi C, Negri F, Panetta A, DI Fabio F and Turci D. The role of cetuximab in pre-treated refractory patients with metastatic colorectal cancer: outcome study in clinical practice. : Journal of chemotherapy (Florence, Italy). 20080804.